/Investor DB

Rabo Corporate Venturing — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

TripleBar Bio, Inc.triplebar.comin𝕏Oct 2023

Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics.

AI & Machine LearningBiotechDeep TechEmeryville, US

Jeremy Agresti(Founder)inHoward Levin(Director)Maria Cho(Executive Officer, Director)

BoardRose Wardle(Director)David Friedberg(Director)in

Co-investorsiSelect FundStray Dog CapitalSynthesis CapitalTPB

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.